Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Alloplex Biotherapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20.67M | Series A | 1/27/2023 | $20.67M | $279.9M | $68.60 | Undisclosed Investors | |||||
| Ally Technologies | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $71.36M | Series C | 2/17/2021 | $45.25M | $349.67M | $26.11 | Greenoaks Capital, Tiger Global Management, Madrona Venture Group, Accel, Addition Ventures, Founders' Co-op, Vulcan Capital | |||||
| Ansun Biopharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $165.2M | Series B | 8/15/2018 | $100M | $466.82M | $1.49 | Lilly Asia Ventures, Matrix Partners China, Yuanming Capital, Lyfe Capital, 3E Bioventures | |||||
| Argyle | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $155.95M | Series C | 3/5/2024 | $30M | $190.82M | $3.83 | Rockefeller Capital Management, Bain Capital Ventures, SignalFire, Checkr, Out of Beta, Mana Ventures, Gaingels | |||||
| ARRIS | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $191.07M | Senior Series C-1 | 4/30/2024 | $27.31M | $192.91M | $2.65 | ST Engineering, Zebra Technologies, Youngone, Standard Industries, Vertex Holdings, NEA, XN, Taiwania Capital, Bosch Ventures, Modern Venture Partners, Alumni Ventures Group | |||||
| Augmodo | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.86M | Series A-4 | 6/30/2026 | $21.17M | $350M | $21.74 | TQ Ventures, Lerer Hippeau, Jefferson River Capital, Arena Holdings, Chemist Warehouse, New Fare, Interlace Ventures, Webb Investment Network | |||||
| Axion Ray | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $63.57M | Series B-1 | 12/15/2025 | $30M | $300M | $10.21 | Salesforce Ventures, Schneider Electric Ventures, Bessemer Venture Partners | |||||
| Balance | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $86.89M | Series B | 7/26/2022 | $56.2M | $361.71M | $10.85 | Forerunner Ventures, Salesforce Ventures, Hubspot Ventures, Lyra Ventures, Gramercy Ventures, Jeff Wisener, Marcelo Cortes, Ribbit Capital, Lightspeed Ventures, Avid Ventures | |||||
| BioTheryX | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $173.09M | Series E | 5/20/2021 | $100M | $348.42M | $5.25 | Farallon Capital Management, Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital management, Alexandria Ventur Investors, Wedbush Helthcare Partners | |||||
| Bland AI | Enterprise Software Productivity | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.96M | Series C | 6/16/2026 | $50M | $462.45M | $14.31 | Scale Venture Partners, Emergence Capital, HubSpot Ventures, Dell Technologies Capital, Upfront Ventures, Archerman Capital, Tribeca Venture Partners, Y Combinator, Max Levchin, Piotr Dabkowski, Jeff Lawson | |||||
| Blee | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $27.49M | Series A-1 Nonvoting | 9/8/2026 | $10M | $270.76M | $2.75 | Fin Capital, SMBC, Hannah Grey VC, National Bank of Canada, Y Combinator, Penny Jar Capital, Cardumen Capital, Treasury | |||||
| Bluejay Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $242.24M | Series C-1 | 5/9/2024 | $1.14M | $371.77M | $6.53 | Frazier Life Sciences, RA Capital Management, T. Rowe Price, Wellington Management, Novo Holdings, RiverVest Venture Partners, Octagon Capital, Arkin Bio Ventures, HBM Healthcare Investments, Unicorn Capital | |||||
| Boston Metal | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $239.02M | Series 2 | 5/20/2026 | $75M | $433.94M | $8.18 | Tata Steel, Climate Investment, Energy Impact Partners, Prelude Ventures | |||||
| Brightseed | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $242.11M | Series B | 5/9/2022 | $68M | $336.32M | $6.38 | Temasek, Lewis & Clark AgriFood, S2G Ventures, CGC Ventures, Germin8, AgFunder | |||||
| Caffeine | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $570.04M | Series AA | 12/20/2023 | $10M | $65.85M | $0.96 | Undisclosed Investors | |||||
| cAMPfield Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $180M | Series A | 6/18/2026 | $177.98M | $297.85M | $5.22 | Frazier Life Sciences, Deep Track Capital, Forbion, Abingworth, Venrock, Longitude Capital, Novo Holdings, RA Capital | |||||
| Cape Analytics | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $94.34M | Series C-1 | 8/5/2022 | $15M | $340.98M | $10.81 | Undisclosed Investors | |||||
| Catchpoint | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $46.25M | Series C-1 | 5/24/2019 | $8M | $157.29M | $2.12 | Sapphire Ventures | |||||
| Censys | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $146.72M | Series D | 3/31/2026 | $40M | $442.95M | $3.34 | Morgan Stanley, Decibel Partners, Greylock, GV, Intel Capital, LDV Partners | |||||
| Central Coast Agriculture | Foodtech Agtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $177.45M | Series C | 1/14/2021 | $99.2M | $474.09M | $5.44 | Artemis Growth Partners | |||||
| Circle Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $303.25M | Series E-1 | 9/16/2026 | $62.01M | $245.27M | $0.27 | The Column Group, Nextech Invest, RA Capital Management, Euclidean, Eli Lilly and Company | |||||
| Clearcover | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $150.2M | Series A-1 | 10/17/2025 | $150.2M | $331.89M | $0.64 | Undisclosed Investors | |||||
| ClearDATA | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $160.84M | Series E | 11/19/2018 | $26M | $220.91M | $0.77 | Excel Venture Management, Flare Capital Partners, HCSC Ventures, Heritage Group, HLM Venture Partners, Merck Global Health Innovation Fund | |||||
| CloudX | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.2M | Series A-4 | 6/18/2026 | $15M | $339.88M | $16.12 | Undisclosed Investors | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.